News and Events

CCR fellows receive Conquer Cancer Foundation of ASCO Young Investigator Awards

Congratulations to Vid Leko M.D., Lekha Mikkilineni, M.D., and Chen Zhao, M.D., for receiving the Conquer Cancer Foundation of ASCO Young Investigator Award (YIA). The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

Bacterial compound targets cancer-promoting RNA

Screening more than 3,000 natural products identified a compound that stops the growth of cancer cells by targeting a growth-promoting microRNA.

Nirali Shah and Lori Wiener participate in AtlanticLIVE summit

Nirali Shah, M.D., MHSc, Investigator in the Pediatric Oncology Branch (POB), and Lori Wiener, Ph.D., DCSW, LCSW-C, Staff Scientist in POB, recently participated in an AtlanticLIVE summit called Children and Cancer. During the event, they discussed their work developing immunotherapies and psychosocial standards of care for children with cancer. Watch their respective sessions here and here.

Udo Rudloff discusses germline mutations with Bloomberg podcast

Udo Rudloff, M.D., Ph.D., Investigator in the Pediatric Oncology Branch, was recently featured on Bloomberg’s Prognosis podcast.During the episode, “Should We Be Scared of Our DNA?," Dr. Rudloff discussed CDH1 germline mutations and risk of hereditary diffuse gastric cancer (HDGC) in an evolving environment, which he is currently studying as part of the Rare Tumor Initiative. The full podcast is available online.

Clinical trial tests new methods for blood stem cell transplant in lymphoma

Peripheral T-cell lymphoma (PTCL) is a rare, often fast-growing cancer of white blood cells. A new clinical trial is investigating to see how a new approach to blood stem cell transplant can impact patients with PTCL.

June is Cancer Immunotherapy Awareness Month

To celebrate Cancer Immunotherapy Month this June, we are highlighting our researchers who have helped pioneer this research and continue to make seminal advances in this growing field.

Investigators test combination therapy for head and neck squamous cell carcinoma in new trial

Patients with recurrent head and neck squamous cell carcinoma (HNSCC) may be eligible to participate in a new clinical trial at the NIH Clinical Center. This trial tests a therapy of a novel radiosensitizer, birinapant, in combination with radiotherapy for patients whose HNSCC has come back at or near the place of the original tumor.

Registration now open for Frontiers in Light Microscopy

The Frontiers in Light Microscopy conference is a platform to discuss the latest advances in microscopy and biological imaging. The current state of the art in light microscopy will be presented by leading researchers in the field who will cover topics such as intravital imaging, super-resolution microscopy and light sheet microscopy. Sessions will include organelle dynamics and function, multicellular organisms and imaging the immune system.

Clinical trial tests a new drug therapy for recurrent ependymomas of the brain and spinal cord

Ependymomas are rare tumors that arise in the ependyma, the thin membrane that lines fluid-filled cavities in the brain and spinal cord, and there are limited treatment options for those that have already been treated with standard therapies. A new clinical trial is testing a drug that targets ependymomas that have a specific genetic signature.

Nataliya Buxbaum wins Magnetic Moments video competition

Nataliya P. Buxbaum, M.D., Assistant Clinical Investigator in the Experimental Transplantation and Immunology Branch, was named the overall winner of the International Society for Magnetic Resonance in Medicine’s Magnetic Moments Competition. The competition is designed for investigators to use video to describe their MRI-related research for a general audience. Dr. Buxbaum’s video describes her research using tracers to better and more safely image tumors.

Breadcrumb